These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 28645061)

  • 1. The neurochemical consequences of methamphetamine self-administration in male and female rats.
    Johansen A; McFadden LM
    Drug Alcohol Depend; 2017 Sep; 178():70-74. PubMed ID: 28645061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurochemical and behavioral comparisons of contingent and non-contingent methamphetamine exposure following binge or yoked long-access self-administration paradigms.
    Schweppe CA; Burzynski C; Jayanthi S; Ladenheim B; Cadet JL; Gardner EL; Xi ZX; van Praag H; Newman AH; Keck TM
    Psychopharmacology (Berl); 2020 Jul; 237(7):1989-2005. PubMed ID: 32388619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methamphetamine self-administration causes persistent striatal dopaminergic alterations and mitigates the deficits caused by a subsequent methamphetamine exposure.
    McFadden LM; Hadlock GC; Allen SC; Vieira-Brock PL; Stout KA; Ellis JD; Hoonakker AJ; Andrenyak DM; Nielsen SM; Wilkins DG; Hanson GR; Fleckenstein AE
    J Pharmacol Exp Ther; 2012 Feb; 340(2):295-303. PubMed ID: 22034657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methamphetamine self-administration acutely decreases monoaminergic transporter function.
    McFadden LM; Stout KA; Vieira-Brock PL; Allen SC; Nielsen SM; Wilkins DG; Hanson GR; Fleckenstein AE
    Synapse; 2012 Mar; 66(3):240-5. PubMed ID: 22120988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuronal dopamine transporter activity, density and methamphetamine inhibition are differentially altered in the nucleus accumbens and striatum with no changes in glycosylation in rats behaviorally sensitized to methamphetamine.
    Bjorklund NL; Sorg BA; Schenk JO
    Synapse; 2008 Oct; 62(10):736-45. PubMed ID: 18651643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extended access to methamphetamine self-administration up-regulates dopamine transporter levels 72 hours after withdrawal in rats.
    D'Arcy C; Luevano JE; Miranda-Arango M; Pipkin JA; Jackson JA; Castañeda E; Gosselink KL; O'Dell LE
    Behav Brain Res; 2016 Jan; 296():125-128. PubMed ID: 26367473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methamphetamine self-administration attenuates hippocampal serotonergic deficits: role of brain-derived neurotrophic factor.
    McFadden LM; Vieira-Brock PL; Hanson GR; Fleckenstein AE
    Int J Neuropsychopharmacol; 2014 Aug; 17(8):1315-20. PubMed ID: 24650575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of subchronic methamphetamine exposure on basal dopamine and stress-induced dopamine release in the nucleus accumbens shell of rats.
    Broom SL; Yamamoto BK
    Psychopharmacology (Berl); 2005 Sep; 181(3):467-76. PubMed ID: 15986185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methamphetamine self-administration is associated with persistent biochemical alterations in striatal and cortical dopaminergic terminals in the rat.
    Krasnova IN; Justinova Z; Ladenheim B; Jayanthi S; McCoy MT; Barnes C; Warner JE; Goldberg SR; Cadet JL
    PLoS One; 2010 Jan; 5(1):e8790. PubMed ID: 20098750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical dopamine transporter inhibitors attenuate compulsive-like methamphetamine self-administration in rats.
    Tunstall BJ; Ho CP; Cao J; Vendruscolo JCM; Schmeichel BE; Slack RD; Tanda G; Gadiano AJ; Rais R; Slusher BS; Koob GF; Newman AH; Vendruscolo LF
    Neuropharmacology; 2018 Mar; 131():96-103. PubMed ID: 29217282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CREB phosphorylation regulates striatal transcriptional responses in the self-administration model of methamphetamine addiction in the rat.
    Krasnova IN; Chiflikyan M; Justinova Z; McCoy MT; Ladenheim B; Jayanthi S; Quintero C; Brannock C; Barnes C; Adair JE; Lehrmann E; Kobeissy FH; Gold MS; Becker KG; Goldberg SR; Cadet JL
    Neurobiol Dis; 2013 Oct; 58():132-43. PubMed ID: 23726845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High levels of intravenous mephedrone (4-methylmethcathinone) self-administration in rats: neural consequences and comparison with methamphetamine.
    Motbey CP; Clemens KJ; Apetz N; Winstock AR; Ramsey J; Li KM; Wyatt N; Callaghan PD; Bowen MT; Cornish JL; McGregor IS
    J Psychopharmacol; 2013 Sep; 27(9):823-36. PubMed ID: 23739178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in the striatal dopamine system during intravenous methamphetamine exposure: effects of contingent and noncontingent administration.
    Laćan G; Hadamitzky M; Kuczenski R; Melega WP
    Synapse; 2013 Aug; 67(8):476-88. PubMed ID: 23417852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methamphetamine-induced changes in the object recognition memory circuit.
    Reichel CM; Ramsey LA; Schwendt M; McGinty JF; See RE
    Neuropharmacology; 2012 Feb; 62(2):1119-26. PubMed ID: 22115899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prior methamphetamine self-administration attenuates the dopaminergic deficits caused by a subsequent methamphetamine exposure.
    McFadden LM; Vieira-Brock PL; Hanson GR; Fleckenstein AE
    Neuropharmacology; 2015 Jun; 93():146-54. PubMed ID: 25645392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of striatal dopamine transporter levels in chronic heroin-dependent and methamphetamine-dependent subjects.
    Yuan J; Liu XD; Han M; Lv RB; Wang YK; Zhang GM; Li Y
    Addict Biol; 2017 Jan; 22(1):229-234. PubMed ID: 26040446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prior methamphetamine self-administration attenuates serotonergic deficits induced by subsequent high-dose methamphetamine administrations.
    McFadden LM; Hunt MM; Vieira-Brock PL; Muehle J; Nielsen SM; Allen SC; Hanson GR; Fleckenstein AE
    Drug Alcohol Depend; 2012 Nov; 126(1-2):87-94. PubMed ID: 22647900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurotoxicity to dopamine neurons after the serial exposure to alcohol and methamphetamine: Protection by COX-2 antagonism.
    Blaker AL; Rodriguez EA; Yamamoto BK
    Brain Behav Immun; 2019 Oct; 81():317-328. PubMed ID: 31228610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GABA, glutamate, dopamine and serotonin transporters expression on memory formation and amnesia.
    Tellez R; Gómez-Víquez L; Meneses A
    Neurobiol Learn Mem; 2012 Feb; 97(2):189-201. PubMed ID: 22183017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amphetamine and methamphetamine reduce striatal dopamine transporter function without concurrent dopamine transporter relocalization.
    German CL; Hanson GR; Fleckenstein AE
    J Neurochem; 2012 Oct; 123(2):288-97. PubMed ID: 22804716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.